Are you a developer of genetic therapies, viral or non-viral gene delivery systems searching for novel therapeutic areas with high unmet need? Consider musculoskeletal medicine! The market is highly attractive, and there is a pressing need for effective molecular therapies. The experienced and specialized scientists of Lunatum Biotech help you to identify interesting disease indications for your technology and develop life-changing, best-in-class gene therapies for patients suffering from debilitating musculoskeletal diseases.
Lunatum Biotech provides a one-stop solution for the preclinical evaluation of novel gene therapy approaches. We support developments in the medical fields of orthopedics and sports medicine, trauma and reconstructive surgery, dentistry and oral surgery, and rheumatology. We aim to address the underserved needs of the pharmaceutical and biotech industry and play a critical role in advancing the field of musculoskeletal gene therapy to improve patients outcomes.
Lunatum Biotech is your research and development partner for musculoskeletal gene medicine. Together we will explore novel opportunities and create advancements in healthcare.
Our clients collaborate directly with our experienced lead scientists and enjoy responsive and clear communication throughout the project. Providing scientific work of high quality and delivering services in a timely manner distinguishes us. Our highly motivated scientists understand your needs and are committed to your scientific and commercial success.
Lunatum Biotech is your reliable and innovative partner for preclinical research and development in the field of molecular musculoskeletal medicine. Our scientists use optimized techniques and work protocols for the isolation and in-depth analysis of on-target and off-target cells. Using a variety of innovative in-vitro modeling systems and in-vivo models, we provide crucial preclinical insights to companies working towards developing targeted genetic drugs for the rapidly expanding orthopedic gene therapy market.
We have exceptional expertise with respect to the following target tissues/organs:
Our experimental work methods include:
Contact us for further details regarding our continuously expanding services.
Osteoporosis, Osteogenesis Imperfecta (OI), Fibrous Dysplasia, Hypophosphatasia, Fibrodysplasia Ossificans Progressiva (FOP), Multiple Epiphyseal Dysplasia (MED), Osteonecrosis, bone tumors, bone metastasis, bone fractures, osseous non-unions, bone defects
Osteoarthritis, cartilage defects, osteochondral defects, Diastrophic Dysplasia
Tendon ruptures, Tendinitis, chronic tendon degeneration, ligament tears
Osteoarthritis, Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
Sarcopenia, Duchenne Muscular Dystrophy, Myasthenia Gravis, Spinal Muscular Atrophy, Polymyalgia Rheumatica, Polymyositis, muscle injuries
Intervertebral Disc Disease
The above listed disorders are just a few examples to show the significance of musculoskeletal medicine. Contact us for further discussions about target diseases and scientific fields of interest.
CEO and founder; post-doctoral training and Instructor at Harvard Medical School; Head of Orthopedic Regenerative Medicine at the University of Munich LMU; Visiting Scientist at MIT; 25 + years of experience in musculoskeletal gene medicine.
Lead scientist; post-doctoral training at Harvard Medical School; Assistant Professor at Einstein College of Medicine; 25 + years of experience in molecular musculoskeletal medicine.
Medical Director and co-founder; post-doctoral training at Harvard Medical School; Orthopedic Surgeon; 20 + years of experience in orthopedic gene therapy.
Please send us a message or call us!
Lunatum Biotech´s phone number:
(+1) 781 518 8894
Lunatum Biotech´s Email:
Lunatum Biotech´s address:
100 Cummings Center, Suite 451C
Beverly, MA 01915